BPC-157 vs GHK
Comparing gastric pentadecapeptide BPC-157 with copper-binding tripeptide GHK for tissue repair research.
Last updated: February 1, 2026
BPC-157
GHK
Overview
BPC-157 and GHK are both peptides of interest in tissue repair research but with different origins and mechanisms. BPC-157 is a synthetic gastric pentadecapeptide, while GHK is a naturally occurring tripeptide that binds copper. Neither is FDA-approved for therapeutic use.
Key Facts
| Aspect | BPC-157 | GHK |
|---|---|---|
| Full Name | Body Protection Compound-157 | Glycyl-L-histidyl-L-lysine |
| Structure | 15 amino acids | 3 amino acids |
| Origin | Gastric juice (synthetic) | Natural tissue peptide |
| Copper Binding | No | Yes (GHK-Cu) |
| FDA Status | Not approved | Not approved (cosmetic use) |
Mechanism Comparison
| Aspect | BPC-157 | GHK |
|---|---|---|
| Primary Mechanism | VEGF, NO system | Copper delivery, gene expression |
| Growth Factors | Upregulates multiple | Stimulates multiple |
| Collagen Effect | May promote synthesis | Promotes synthesis |
| Wound Healing | Proposed | Established (in vitro) |
How They Work
BPC-157:
- Proposed to modulate nitric oxide system
- May enhance VEGF expression
- Claimed effects on multiple tissue types
- Mechanism not fully characterized
GHK:
- Binds copper as GHK-Cu complex
- Influences gene expression (thousands of genes)
- Promotes collagen and elastin synthesis
- Enhances wound healing in studies
Evidence Comparison
| Aspect | BPC-157 | GHK |
|---|---|---|
| Human Trials | 1-2 (limited) | Cosmetic studies |
| Animal Studies | Numerous (one group) | Multiple groups |
| In Vitro Data | Moderate | Substantial |
| Independent Replication | Limited | More extensive |
BPC-157 Research Concerns
- Majority of research from single Croatian group
- Limited independent replication
- Mechanism not fully elucidated
- No active pharmaceutical development
GHK Research
- More established science
- Multiple research groups
- Clear copper-binding mechanism
- Cosmetic applications studied
Application Focus
| Use | BPC-157 | GHK |
|---|---|---|
| Wound Healing | Claimed (animal data) | Studied (cosmetic) |
| Tendon/Muscle | Primary claim | Less emphasized |
| Skin | Secondary | Primary |
| GI Tract | Primary (origin) | Not emphasized |
| Anti-aging | Claimed | Primary cosmetic use |
Administration Routes
| Route | BPC-157 | GHK |
|---|---|---|
| Injection (SC/IM) | Common (research) | Rare |
| Oral | Some claims | Not studied |
| Topical | Less common | Primary (cosmetics) |
| Stability | Requires care | Relatively stable |
Safety Profile
BPC-157
| Aspect | Information |
|---|---|
| Human Safety Data | Very limited |
| Long-term Effects | Unknown |
| Contraindications | Unknown |
| Quality Concerns | Gray market purity issues |
GHK
| Aspect | Information |
|---|---|
| Human Safety Data | Cosmetic use data exists |
| Topical Safety | Generally well-tolerated |
| Systemic Safety | Limited data |
| Quality | Cosmetic-grade available |
Regulatory Status
| Aspect | BPC-157 | GHK |
|---|---|---|
| FDA Status | Not approved | Not approved |
| Cosmetic Use | Not typical | Allowed |
| Drug Development | None active | Not pursued |
| WADA Status | Prohibited | Not listed |
Commercial Availability
| Factor | BPC-157 | GHK |
|---|---|---|
| Sources | Research chemical | Research + cosmetic |
| Cosmetic Products | No | Yes (GHK-Cu) |
| Quality Control | None (research) | Variable |
| Topical Forms | Limited | Widespread |
Proposed Effects (Not Verified)
BPC-157 Claims
| Claim | Evidence Level |
|---|---|
| Tendon healing | Animal data |
| Muscle repair | Animal data |
| GI protection | Animal data (origin) |
| Anti-inflammatory | Animal data |
| Systemic healing | Limited, speculative |
GHK/GHK-Cu Claims
| Claim | Evidence Level |
|---|---|
| Wound healing | In vitro, some human |
| Collagen production | In vitro |
| Anti-aging (skin) | Cosmetic studies |
| Antioxidant | In vitro |
| Gene expression | Well-documented |
Key Differences
| Factor | BPC-157 | GHK |
|---|---|---|
| Size | 15 amino acids | 3 amino acids |
| Copper binding | No | Yes (essential) |
| Primary route | Injection (research) | Topical |
| Research base | Limited sources | Broader |
| Cosmetic use | No | Yes |
| Mechanism clarity | Unclear | Better understood |
Summary
- BPC-157 is a gastric-derived peptide with animal data for tissue repair but limited independent verification
- GHK is a copper-binding tripeptide with clearer mechanism and cosmetic applications
- BPC-157 research concentrated from single group; GHK more broadly studied
- GHK has established cosmetic use; BPC-157 has no approved applications
- Neither is FDA-approved for therapeutic use
- Quality concerns exist for both, especially BPC-157 from gray market
This comparison is for educational purposes only. Neither peptide is approved for therapeutic use. BPC-157 products are unregulated research chemicals. GHK-Cu is available in cosmetics but not approved as a drug.
View Full Dossiers
Stay Updated on Peptide Comparisons
Get notified when we publish new comparison dossiers and evidence reviews.
No spam. Unsubscribe anytime.
Disclaimer: This comparison is for educational purposes only and does not constitute medical advice. Individual responses to medications vary. Always consult a qualified healthcare provider before making treatment decisions.